Biotech sector gains traction amid broader market decline, with the XBI ETF briefly dipping below its 21-day moving average.
Biotech stocks emerged as relative outperformers Friday as the Nasdaq extended losses, driven by a sell-off in semiconductor and AI-related equities. The SPDR S&P Biotech ETF (XBI) briefly fell below its 21-day exponential moving average before stabilizing, reflecting mixed sentiment in the sector.
The tech-heavy Nasdaq has faced downward pressure in recent sessions, with high-flying AI stocks retreating from record highs. Meanwhile, biotech names have attracted investor attention, with growth screens highlighting strong performers in the space.
Market participants continue to monitor sector rotation dynamics as macroeconomic uncertainty persists, with biotech resilience contrasting broader tech weakness.